Class information for:
Level 1: PSORIASIS//EFALIZUMAB//USTEKINUMAB

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
2611 2196 42.0 84%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
188 3       DERMATOLOGY//CONTACT DERMATITIS//PSORIASIS 55369
551 2             PSORIASIS//PSORIATIC ARTHRITIS//DERMATOLOGY 14610
2611 1                   PSORIASIS//EFALIZUMAB//USTEKINUMAB 2196

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 PSORIASIS authKW 1846329 41% 15% 893
2 EFALIZUMAB authKW 661469 3% 65% 73
3 USTEKINUMAB authKW 565678 4% 47% 87
4 ALEFACEPT authKW 485322 2% 73% 48
5 INVEST DERMATOL address 248117 3% 31% 57
6 ETANERCEPT authKW 234026 7% 11% 152
7 SECUKINUMAB authKW 227048 2% 47% 35
8 DERMATOL address 190753 52% 1% 1152
9 BIOLOGICS authKW 175357 6% 10% 123
10 BRODALUMAB authKW 168508 1% 61% 20

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 Dermatology 147084 62% 1% 1357
2 Immunology 1381 14% 0% 298
3 Pharmacology & Pharmacy 413 11% 0% 231
4 Medicine, Research & Experimental 373 6% 0% 132
5 Allergy 181 2% 0% 34
6 Rheumatology 110 2% 0% 35
7 Pathology 106 3% 0% 59
8 Medicine, General & Internal 47 4% 0% 87
9 Integrative & Complementary Medicine 10 0% 0% 9
10 Health Care Sciences & Services 8 1% 0% 19

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 INVEST DERMATOL 248117 3% 31% 57
2 DERMATOL 190753 52% 1% 1152
3 INVESTIGAT DERMATOL 153535 1% 41% 27
4 MURDOUGH FAMILY PSORIASIS 60230 1% 33% 13
5 MILSTEIN MED PROGRAM 41710 0% 100% 3
6 PROB MED 41710 0% 100% 3
7 CENT DERMATOL 37073 0% 67% 4
8 PSORIASIS 35833 1% 18% 14
9 SALFORD ROYAL HOSP 32374 1% 14% 17
10 IMMUNOL BIOMARKERS 31775 0% 57% 4

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 JOURNAL OF CUTANEOUS MEDICINE AND SURGERY 51501 3% 7% 55
2 JOURNAL OF DERMATOLOGICAL TREATMENT 49304 3% 5% 69
3 BRITISH JOURNAL OF DERMATOLOGY 42653 8% 2% 184
4 JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31142 4% 3% 90
5 JOURNAL OF DRUGS IN DERMATOLOGY 26031 3% 3% 56
6 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 19460 6% 1% 131
7 AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 18119 1% 4% 31
8 JOURNAL OF INVESTIGATIVE DERMATOLOGY 16443 5% 1% 112
9 SEMINARS IN CUTANEOUS MEDICINE AND SURGERY 15350 1% 4% 29
10 EXPERIMENTAL DERMATOLOGY 10711 2% 2% 45

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 PSORIASIS 1846329 41% 15% 893 Search PSORIASIS Search PSORIASIS
2 EFALIZUMAB 661469 3% 65% 73 Search EFALIZUMAB Search EFALIZUMAB
3 USTEKINUMAB 565678 4% 47% 87 Search USTEKINUMAB Search USTEKINUMAB
4 ALEFACEPT 485322 2% 73% 48 Search ALEFACEPT Search ALEFACEPT
5 ETANERCEPT 234026 7% 11% 152 Search ETANERCEPT Search ETANERCEPT
6 SECUKINUMAB 227048 2% 47% 35 Search SECUKINUMAB Search SECUKINUMAB
7 BIOLOGICS 175357 6% 10% 123 Search BIOLOGICS Search BIOLOGICS
8 BRODALUMAB 168508 1% 61% 20 Search BRODALUMAB Search BRODALUMAB
9 IXEKIZUMAB 167288 1% 63% 19 Search IXEKIZUMAB Search IXEKIZUMAB
10 APREMILAST 163926 1% 47% 25 Search APREMILAST Search APREMILAST

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 DI MEGLIO, P , VILLANOVA, F , NESTLE, FO , (2014) PSORIASIS.COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. VOL. 4. ISSUE 8. P. - 98 48% 12
2 FRAMPTON, JE , PLOSKER, GL , (2009) EFALIZUMAB A REVIEW OF ITS USE IN THE MANAGEMENT OF CHRONIC MODERATE-TO-SEVERE PLAQUE PSORIASIS.AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. VOL. 10. ISSUE 1. P. 51-72 59 91% 15
3 MANSOURI, B , PATEL, M , MENTER, A , (2013) BIOLOGICAL THERAPIES FOR PSORIASIS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 13. ISSUE 12. P. 1715 -1730 75 61% 7
4 LOWES, MA , SUAREZ-FARINAS, M , KRUEGER, JG , (2014) IMMUNOLOGY OF PSORIASIS.ANNUAL REVIEW OF IMMUNOLOGY, VOL 32. VOL. 32. ISSUE . P. 227-255 56 43% 126
5 CLINE, A , HILL, D , LEWALLEN, R , FELDMAN, SR , (2016) CURRENT STATUS AND FUTURE PROSPECTS FOR BIOLOGIC TREATMENTS OF PSORIASIS.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 12. ISSUE 12. P. 1273 -1287 64 63% 0
6 TSAI, YC , TSAI, TF , (2016) A REVIEW OF CLINICAL TRIALS OF BIOLOGIC AGENTS AND SMALL MOLECULES FOR PSORIASIS IN ASIAN SUBJECTS.GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. VOL. 151. ISSUE 4. P. 412 -431 41 87% 1
7 BURNESS, CB , MCKEAGE, K , (2015) ADALIMUMAB: A REVIEW IN CHRONIC PLAQUE PSORIASIS.DRUGS. VOL. 75. ISSUE 18. P. 2119 -2130 47 78% 2
8 JOHNSON-HUANG, LM , LOWES, MA , KRUEGER, JG , (2012) PUTTING TOGETHER THE PSORIASIS PUZZLE: AN UPDATE ON DEVELOPING TARGETED THERAPIES.DISEASE MODELS & MECHANISMS. VOL. 5. ISSUE 4. P. 423-433 68 52% 36
9 MAHIL, SK , CAPON, F , BARKER, JN , (2016) UPDATE ON PSORIASIS IMMUNOPATHOGENESIS AND TARGETED IMMUNOTHERAPY.SEMINARS IN IMMUNOPATHOLOGY. VOL. 38. ISSUE 1. P. 11 -27 67 44% 3
10 LOWES, MA , RUSSELL, CB , MARTIN, DA , TOWNE, JE , KRUEGER, JG , (2013) THE IL-23/T17 PATHOGENIC AXIS IN PSORIASIS IS AMPLIFIED BY KERATINOCYTE RESPONSES.TRENDS IN IMMUNOLOGY. VOL. 34. ISSUE 4. P. 174-181 49 53% 86

Classes with closest relation at Level 1



Rank Class id link
1 13913 PSORIASIS//PSORS1//GUTTATE PSORIASIS
2 7006 PSORIASIS//PSYCHODERMATOLOGY//DERMATOLOGY LIFE QUALITY INDEX
3 8717 PSORIASIS//PSORIATIC ARTHRITIS//PSORIATIC NEPHROPATHY
4 15661 VOCLOSPORIN//SOLUBLE MEMBRANE MOLECULES//UVB DITHRANOL TREATMENT
5 4996 PSORIATIC ARTHRITIS//NAIL PSORIASIS//PSORIAT ARTHRIT PROGRAM
6 16155 INFLIXIMAB//DRUG INDUCED LUPUS//ADALIMUMAB
7 25275 CLIN MOL SCI HISTOL//NATIVE CAPILLAROSCOPY//TOPCAM
8 22033 CHILDHOOD PSORIASIS//ACRODERMATITIS CONTINUA OF HALLOPEAU//PERIANAL STREPTOCOCCAL DERMATITIS
9 7545 CALCIPOTRIOL//BETAMETHASONE DIPROPIONATE//TACALCITOL
10 37474 BNX TRANSPLANTED SKIN MODEL//COLUMNAR EPIDERMAL NECROSIS//DORSUM LINGUAE

Go to start page